Free Trial

The Joint Corp. (NASDAQ:JYNT) Short Interest Down 7.7% in October

Joint logo with Medical background

The Joint Corp. (NASDAQ:JYNT - Get Free Report) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 487,300 shares, a decrease of 7.7% from the October 15th total of 528,100 shares. Based on an average daily trading volume, of 48,800 shares, the short-interest ratio is presently 10.0 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in JYNT. Squarepoint Ops LLC acquired a new position in shares of Joint during the 2nd quarter valued at about $144,000. Sargent Investment Group LLC acquired a new stake in Joint during the second quarter worth $150,000. FMR LLC lifted its position in Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company's stock valued at $123,000 after buying an additional 2,971 shares during the last quarter. XTX Topco Ltd purchased a new position in Joint during the second quarter worth about $174,000. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Joint by 5.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company's stock valued at $229,000 after acquiring an additional 837 shares during the period. Hedge funds and other institutional investors own 76.88% of the company's stock.

Joint Stock Down 2.4 %

Shares of NASDAQ:JYNT traded down $0.26 during trading on Monday, reaching $10.80. 217,987 shares of the company's stock traded hands, compared to its average volume of 68,676. The firm has a market cap of $161.83 million, a PE ratio of -9.70 and a beta of 1.57. Joint has a fifty-two week low of $8.38 and a fifty-two week high of $17.82. The company has a 50-day simple moving average of $11.31 and a 200-day simple moving average of $12.95.

Analyst Ratings Changes

Several brokerages have recently issued reports on JYNT. Roth Mkm reduced their price objective on Joint from $16.00 to $15.00 and set a "buy" rating for the company in a research note on Friday, November 8th. StockNews.com upgraded shares of Joint from a "hold" rating to a "buy" rating in a research report on Friday.

View Our Latest Stock Report on JYNT

Joint Company Profile

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

See Also

Should you invest $1,000 in Joint right now?

Before you consider Joint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.

While Joint currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines